Dimethyl fumarate Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetil fumarat - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Europska Unija - hrvatski - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetil fumarat - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Europska Unija - hrvatski - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetil fumarat - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Europska Unija - hrvatski - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetil fumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetil fumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Vumerity Europska Unija - hrvatski - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Dentinox N gel za desni Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dentinox n gel za desni

dentinox gesellschaft für pharmazeutische präparate, lenk & schuppan kg, nunsdorfer ring 19, berlin, njemačka - tinktura kamilice lidokainklorid hidrat lauromakrogol 400 - gel za desni - 150 mg + 3,4 mg + 3,2 mg - urbroj: 1 g gela sadrži: 150,0 mg tinkture iz matricaria recutita l., flos (kamiličin cvijet) (1:4-4.5), ekstrakcijsko otapalo: etanol 70 % v/v; 3,4 mg lidokainklorid hidrata i 3,2 mg lauromakrogola 400.

BCG-medac prašak i otapalo za intravezikalnu suspenziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

bcg-medac prašak i otapalo za intravezikalnu suspenziju

medac gesellschaft für klinische spezialpräparate mbh, theaterstraße 6, wedel, njemačka - bakterija bcg (bacillus calmette guérin), soj rivm (izveden iz soja 1173-p2 (živa, atenuirana)) - prašak i otapalo za intravezikalnu suspenziju - 2x10^8 do 3x10^9 vijabilnih jedinica - urbroj: nakon rekonstitucije jedna bočica sadrži: bcg (bacillus calmette guérin) bakterija mycobacterium bovis, živa, atenuirana, soj rivm izveden iz soja 1173-p2: 2x10^8 do 3x10^9 vijabilnih jedinica

Metoject 50 mg/ml otopina za injekciju u napunjenoj štrcaljki Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

metoject 50 mg/ml otopina za injekciju u napunjenoj štrcaljki

medac gesellschaft für klinische spezialpräparate mbh, theaterstraße 6, wedel, njemačka - dinatrijev metotreksat - otopina za injekciju u napunjenoj štrcaljki - 50 mg/ml - urbroj: 1 ml otopine sadrži 50 mg metotreksata (u obliku dinatrijevog metotreksata)

Tecfidera Europska Unija - hrvatski - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dimetil fumarat - multipla skleroza - imunosupresivi - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).